Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/immunology.3.083
IL-10 Responsiveness and Anti-TNF Therapy in Inflammatory Bowel Disease
Felicia M. Bloemendaal1,2, Charlotte P. Peters1, Anje A. te Velde1,2, Cyriel Y. Ponsioen1, Gijs R. van den Brink1,2,3, Manon E. Wildenberg1,2,#, Pim J. Koelink2,#,*
- 1Department of Gastroenterology and Hepatology, University of Amsterdam, Amsterdam, the Netherlands
- 2Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, location AMC, AG&M Amsterdam, University of Amsterdam, Amsterdam, the Netherlands
- 3Current address: Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Basel, Switzerland
- #Contributed equally
Pim J. Koelink, firstname.lastname@example.org
Received Date: December 05, 2020
Accepted Date: January 28, 2021
Bloemendaal FM, Peters CP, te Velde AA, Ponsioen CY, van den Brink GR, Wildenberg ME, et al. IL-10 Responsiveness and Anti-TNF Therapy in Inflammatory Bowel Disease. J Cell Immunol. 2021; 3(2): 91-96.
Copyright: © 2021 Bloemendaal FM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
IBD, IL-10, Anti-TNF, Macrophages, Colitis